se of multiple frequency Bioimpedance in determining the status of hydration and its impact on blood pressure control, arterial stiffness, cardiac changes, and inflammation status in peritoneal dialysis
- Conditions
- Other dialysisC12.777.419.780.750
- Registration Number
- RBR-10k8j3bx
- Lead Sponsor
- Faculdade de Medicina de Botucatu - Universidade Estadual Paulista Júlio de Mesquita Filho
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Patients over the age of 18, on a peritoneal dialysis program for a period of three months or more, who agreed to participate by signing the informed consent form.
Cardiac pacemakers, metallic implants, amputees, malignant neoplasms, liver cirrhosis, active infectious diseases, unstable heart diseases (acute coronary syndrome, unstable arrhythmias), and severe left ventricular systolic dysfunction (ejection fraction below 30%). The interruption of follow-up will be indicated when there are adverse treatment effects that cannot be controlled by the routine dialysis procedure, such as refractory hypervolemia and arterial hypotension; acute infections, in addition to acute cardiovascular and cerebrovascular events and the express manifestation of the patient by the discontinuation of the intervention protocol.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of 5% in the measure of relative hyperhydration (OH/AEC%) between the groups at the end of the intervention, evaluated by bioimpedance spectroscopy, with an estimated standard deviation of 4.8%
- Secondary Outcome Measures
Name Time Method Difference of 12 mmHg in mean systolic blood pressure between groups at the end of the intervention, measured by the 24-hour ambulatory blood pressure monitoring device, with an estimated standard deviation of 17 mmHg